Neurotoxicity Research

, Volume 9, Issue 2–3, pp 189–196 | Cite as

Botulinum toxin treatment of children with cerebral palsy — a short review of different injection techniques

  • A. S. Schroeder
  • S. Berweck
  • S. H. Lee
  • F. Heinen


The intramuscular application of botulinum toxin type A (BoNT/A) has emerged to be an established treatment option to reduce muscular hyperactivity due to spasticity in children with cerebral palsy. Accurate injection is a prerequisite for efficient and safe treatment with BoNT/A. So far, treatment procedures have not been standardized. This paper is a short review of different injection techniques, i.e., manual needle placement as well as guidance by electromyography, electrical stimulation, and ultrasound. Advantages and disadvantages of the different injection techniques are discussed with a focus on needle positioning within the targeted muscle, injection close to the neuromuscular junction and diffusion of BoNT/A within the target muscles and through fascia. The additional information gained by each injection technique is weighed in terms of the clinical impact for children with cerebral palsy.


Botulinum toxin Cerebral palsy Ultrasound Electrical stimulation EMG Neuromuscular junction Diffusion Dilution 



botulinum toxin type A


cerebral palsy




Gross motor function classification system


motor evoked potential


neuromuscular junctions


unit (mouse units of botulinum toxin type A)


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Barbano RL (2001) Needle EMG guidance for injection of botulinum toxin. Needle EMG guidance is useful.Muscle Nerve 24(11), 1567–1568.PubMedCrossRefGoogle Scholar
  2. Berweck S and F Heinen (2004) Use of botulinum toxin in pediatric spasticity (cerebral palsy).Mov. Disord. 19 Suppl. 8, S162–S167.PubMedCrossRefGoogle Scholar
  3. Berweck S, A Feldkamp, A Francke, J Nehles, A Schwerin and F Heinen (2002) Sonography-guided injection of botulinum toxin A in children with cerebral palsy.Neuropediatrics 33(4), 221–223.PubMedCrossRefGoogle Scholar
  4. Berweck S, AS Schroeder and F Heinen (2004) Sonography-guided injection of botulinum toxin in children with cerebral palsy.The Lancet 363(9404), 249–250.CrossRefGoogle Scholar
  5. Borodic GE, R Ferrante, LB Pearce and K Smith (1994) Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections.Mov. Disord. 9(1), 31–39.PubMedCrossRefGoogle Scholar
  6. Borodic GE, M Joseph, L Fay, D Cozzolino and RJ Ferrante (1990) Botulinum A toxin for the treatment of spasmodic torticollis: dyspha-gia and regional toxin spread.Head Neck 12(5), 392–399.PubMedCrossRefGoogle Scholar
  7. Brans JW, IP de Boer, M Aramideh, B W Ongerboer, L de Visser and JD Speelman (1995) Botulinum toxin in cervical dystonia: low dosage with electromyographic guidance.J. Neurol. 242, 529–534.PubMedCrossRefGoogle Scholar
  8. Chin TY, GR Nattrass, P Selber and HK Graham (2005) Accuracy of intramuscular injection of botulinum toxin A in juvenile cerebral palsy: a comparison between manual needle placement and placement guided by electrical stimulation.J. Pediatr. Orthop. 25(3), 286–291.CrossRefGoogle Scholar
  9. Comella CL, AS Buchman, CM Tanner, NC Brown-Toms and CG Goetz (1992) Botulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistance.Neurology 42(4), 878–382.CrossRefGoogle Scholar
  10. Cosgrove AP, IS Corry and HK Graham (1994) Botulinum toxin in the management of the lower limb in cerebral palsy.Dev. Med. Child Neurol. 36(5), 386–396.PubMedCrossRefGoogle Scholar
  11. Damiano DL and MF Abel (1998) Functional outcomes of strength training in spastic cerebral palsy.Arch. Phys. Med. Rehabil. 79, 119–125.PubMedCrossRefGoogle Scholar
  12. Detrembleur C, TM Lejeune, A Renders and PY Van Den Bergh (2002) Botulinum toxin and short-term electrical stimulation in the treatment of equinus in cerebral palsy.Mov. Disord. 17(1), 162–169.PubMedCrossRefGoogle Scholar
  13. Dressler D and JC Rothwell (2000) Electromyographic quantification of the paralysing effect of botulinum toxin in the sternocleidomastoid muscle.Eur. Neurol. 43(1), 13–16.PubMedCrossRefGoogle Scholar
  14. Fischer AQ, DW Carpenter, PL Hartlage, JE Carroll and S Stephens (1988) Muscle imaging in neuromuscular disease using computerized real-time sonography.Muscle Nerve 11(3), 270–275.PubMedCrossRefGoogle Scholar
  15. Francisco GE, C Boake and A Vaughn (2002) Botulinum toxin in upper limb spasticity after acquired brain injury: a randomized trial comparing dilution techniques.Am. J. Phys. Med. Rehabil. 81(5), 355–363.PubMedCrossRefGoogle Scholar
  16. Gracies J-M, D-J Weiszet al. (2002) Impact of botulinum toxin A (BTX-A) dilution and endplate targeting technique in upper limb spasticity.Ann. Neurol. Suppl.1, S87.Google Scholar
  17. Graham HK, KR Aoki, I Autti-Ramo, RN Boyd, MR Delgado, DJ Gaebler-Spira, ME Gormley, BM Guyer, F Heinen, AF Holton, D Matthews, G Molenaers, F Motta, PJ Garcia Ruiz and J Wissel (2000) Recommendations for the use of botulinum toxin type A in the management of cerebral palsy.Gait Posture 11(1), 67–79.PubMedCrossRefGoogle Scholar
  18. Hesse S, MT Jahnke, D Luecke and KH Mauritz (1995) Short-term electrical stimulation enhances the effectiveness of botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients.Neurosci. Lett. 201(1), 37–40.PubMedCrossRefGoogle Scholar
  19. Jankovic J (2001) Needle EMG guidance for injection of botulinum toxin. Needle EMG guidance is rarely required.Muscle Nerve 24(11), 1568–1570.PubMedCrossRefGoogle Scholar
  20. Kinnett D (2004) Botulinum toxin A injections in children: technique and dosing issues.Am. J. Phys. Med. Rehabil. 83(10 Suppl.), S59-S64.PubMedCrossRefGoogle Scholar
  21. Koman LA, F Mooney, B Smith, A Goodman and T Mulvaney (1993) Management of cerebral palsy with botulinum A toxin: preliminary investigation.J. Pediatr. Orthop. 13(4), 489–495.PubMedCrossRefGoogle Scholar
  22. Koman LA, JF Mooney 3rd, BP Smith, F Walker and JM Leon (2000) Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group.J. Pediatr. Orthop. 20(1), 108–115.PubMedGoogle Scholar
  23. Lieber RL, S Steinman, IA Barash and H Chambers (2004) Structural and functional changes in spastic skeletal muscle.Muscle Nerve 29(5), 615–627.PubMedCrossRefGoogle Scholar
  24. Rose J and KC McGill (2005) Neuromuscular activation and motor-unit firing characteristics in cerebral palsy.Dev. Med. Child Neurol. 47(5), 329–336.PubMedCrossRefGoogle Scholar
  25. Shaari CM, E George, BL Wu, HF Biller and I Sanders (1991) Quantifying the spread of botulinum toxin through muscle fascia.Laryngoscope 101, 960–964.PubMedCrossRefGoogle Scholar
  26. Shaari CM and I Sanders (1993) Quantifying how location and dose of botulinum toxin injections affect muscle paralysis.Muscle Nerve 16(9), 964–969.PubMedCrossRefGoogle Scholar
  27. Shortland AP, CA Harris, M Gough and RO Robinson (2002) Architecture of the medial gastrocnemius in children with spastic diplegia.Dev. Med. Child Neurol. 44(3), 158–163.PubMedCrossRefGoogle Scholar
  28. Simpson LL (1980) Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction.J. Pharmacol. Exp. Ther. 212(1), 16–21.PubMedGoogle Scholar
  29. Stackhouse SK, SA Binder-Macleod and SC Lee (2005) Voluntary muscle activation, contractile properties, and fatigability in children with and without cerebral palsy.Muscle Nerve 31(5), 594–601.PubMedCentralPubMedCrossRefGoogle Scholar
  30. Ubhi T, BB Bhakta, HL Ives, V Allgar and SH Roussounis (2000) Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy [In Process Citation].Arch. Dis. Child. 83(6), 481–487.PubMedCentralPubMedCrossRefGoogle Scholar
  31. Westhoff B, K Seller, A Wild, JM Jaeger and R Krauspe (2003) Ultrasound-guided botulinum toxin injection technique for the ilio-psoas muscle.Dev. Med. Child. Neurol. 45(12), 829–832.PubMedCrossRefGoogle Scholar
  32. Willenborg MJ, JS Shilt, BP Smith, RL Estrada, JA Castle and LA Koman (2002) Technique for iliopsoas ultrasound-guided active electromyography-directed botulinum a toxin injection in cerebral palsy.J. Pediatr. Orthop. 22(2), 165–168.PubMedGoogle Scholar
  33. Wissel J and W Poewe (2003) EMG for identification of dystonic, tremulous and spastic muscles and techniques for guidance of injections, In:Handbook of Botulinum Toxin Treatment, 2nd Edition (Moore NM, Ed.) (Blackwell Science:Oxford), pp 76–98.Google Scholar

Copyright information

© Springer 2006

Authors and Affiliations

  • A. S. Schroeder
    • 1
  • S. Berweck
    • 1
  • S. H. Lee
    • 1
  • F. Heinen
    • 1
  1. 1.Dr. von Hauner’s Children’s Hospital, Department of Paediatric Neurology and Developmental MedicineUniversity of MunichMunichGermany

Personalised recommendations